iiinova — where your digital self keeps evolving

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 15/01/2026

This paper shows that DNMT3A-mutant blood stem cells, present but undetectable in young donors, can expand into clonal hematopoiesis decades after transplantation. The authors highlight that environmental pressures, not just new mutations, drive this process. Read here 👉https://bit.ly/3XLdF1m

021

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 04/12/2025

#HemaSphere is heading to #ASH25 Are you interested to learn more? Looking to discuss your manuscript? Curious about who we are? Reach out - we can set a meeting time. Jessica will also be available at the #EHA booth (1482) at various times. See you in Orlando!

021

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 31/10/2025

Explore the latest research lurking in our October issue… if you dare! 🎃👻🧟‍♀️http://bit.ly/4haMwh3

012

Jan Cools @jancools.bsky.social · 18/09/2025

Looking forward to this exciting meeting and to represent @hemasphere-journal.bsky.social in this session!

021

Jan Cools @jancools.bsky.social · 05/08/2025

Great mix of art & science at the Art Science Museum in Singapore.

110

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 30/06/2025

In this study the authors show how cancer associated fibroblasts and their spatial architecture in the tumor microenvironment impact survival in patients with cHL. Read more about it here 👉https://bit.ly/4mdhPK6

011

Jan Cools @jancools.bsky.social · 18/06/2025

Exciting to share the new impact factor of @hemasphere-journal.bsky.social, the #openaccess journal of the European Hematology Association (EHA). The 2024 Journal Impact Factor is 14.6 - ranking as number 5 of 99 hematology journals (Source: Journal Citations Reports, Clarivate).

0112

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 14/06/2025

🚨Today! @ 15:45, MiCo room CORAL 6 We warmly invite you to the HemaSphere Scientific Session where we will dive into 3 of our exciting + cutting-edge biology publications. Hope to see you there! 🕰️: 15:45 - 16:45 📍: Room CORAL 6, #EHA2025 🎤: bit.ly/4koLwXk

053

Jan Cools @jancools.bsky.social · 14/06/2025

Thank you EHA, for honoring me with the Education and Mentoring Award. Thank you Peter Marynen and Gary Gilliland for being such inspiring mentors to me! Thank you to all my trainees, all current and past members of my research group. #EHA2025 @hemasphere-journal.bsky.social

1101

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 29/05/2025

Heading to #EHA2025 in Milan in 1.5(ish) weeks? HemaSphere has 2 exciting sessions on the program! 📌Peer Review Workshop: Fri 13 June, 13:30 - 15:00 💡Learn + master the peer review role/process 📌HemaSphere Scientific Session: Sat 14 June, 15:45 - 16:45 💡Dive into 3 of our cutting-edge biology papers

042

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 11/04/2025

This study examines the frequency of recurring gene mutations and their interplay with well-known biomarkers in female and male patients, between 18-80 years, with ref/rel DLBCL compared to patients with CR to identify biological risk factors associated with treatment response👉https://bit.ly/4ihynhR

021

Reposted by Jan Cools

Charles de Bock @charles-debock.bsky.social · 17/02/2025

If you are interested in learning about #PDX models in in vivo drug testing, take the time to listen to the following @hemasphere-journal.bsky.social podcast featuring Prof Richard Lock. 👇

021

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 31/01/2025

This study quantified Bcl-2 family protein expression in newly diagnosed MM patients. High levels of Bad and Puma proteins were linked to longer OS. Bcl-2 protein ratios predicting venetoclax sensitivity distinguished patients with shorter progression times 👉https://bit.ly/4fUpV6c

021

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 29/01/2025

We're proud to be fully open access - from day one, in fact.

031

Jan Cools @jancools.bsky.social · 22/01/2025

On my way to Prague for their national hematology meeting, with my ‘retro’ EHA bag… this must be very old considering the logo…but still very useful 😊

220

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 13/01/2025

📢 Authors evaluated the efficacy JPX-0700 and JPX-0750 as dual STAT3/5 inhibitors, reducing leukemic cell growth in AML/NKCL models. These compounds target STAT3/5 signaling, inducing cell death and growth arrest and exhibit synergistic effects w/ approved chemotherapeutics👉https://bit.ly/42oMtJp

052

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 31/12/2024

2024 has been a successful year for HemaSphere Journal! 800+ manuscript submissions increasing impact in the field insightful graphical abstracts another podcast season ...and of course, excellent research! We extend a warm thank you to all authors, reviewers & readers ❤️

041

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 28/12/2024

📖HemaSphere's December issue is now complete 👉https://bit.ly/HS_Dec2024 and as always, is 100% #OpenAccess. Please enjoy reading and feel free to share with your networks.

021

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 24/12/2024

Microbes support normal blood production! Authors in this recently published article report on the microbes and microbial metabolites missing from pediatric patients with antibiotic-associated neutropenia. @TheKingLab 👉https://bit.ly/4fUXyWe

041

Reposted by Jan Cools

ISEH - International Society for Experimental Hematology @isehsociety.bsky.social · 20/12/2024

Save the date for ISEH 2025! View travel details and Annual Scientific Meeting Speakers here: www.iseh.org/page/iseh2025

096

Reposted by Jan Cools

HemaSphere Journal @hemasphere-journal.bsky.social · 16/12/2024

This pop-based study examines COD in 20K+ CLL pts in the Netherlands from 1996-2020. This analysis shows a noticeable ⬇️ in CLL-attributed deaths & other causes yet as CLL is registered as the most prevalent COD this emphasizes the relevance of CLL-centric clinical strategies👉https://bit.ly/4iqC859

011

Jan Cools @jancools.bsky.social · 14/12/2024

Very proud that my lab won the second prize of the dance competition at our VIB Center for Cancer Biology party last night 🎉🤩🥂

130

Jan Cools @jancools.bsky.social · 24/11/2024

Stay up-to-date on new findings in the hematology field - read the free HemaTopics articles in HemaSphere onlinelibrary.wiley.com/doi/full/10....

onlinelibrary.wiley.com

IL‐11—An aging‐related cytokine with opportunities for regulating hematopoiesis

Click on the article title to read more.

031